医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
16期
174-175
,共2页
舒心胶囊%不稳定型心绞痛%C-反应蛋白%血脂
舒心膠囊%不穩定型心絞痛%C-反應蛋白%血脂
서심효낭%불은정형심교통%C-반응단백%혈지
Shuxin capsule%Unstable angina pectoris%C-reactive protein%Blood lipid
目的：探讨舒心胶囊治疗不稳定型心绞痛（UAP）的临床疗效及对C-反应蛋白（CRP）和血脂水平的影响。方法将60例UAP患者随机分为两组，每组各30例，均给予常规西药治疗，治疗组在此基础上加用舒心胶囊，比较两组临床疗效及治疗前后血清CRP和血脂各项指标变化。结果治疗组心绞痛有效率和心电图有效率分别为90.00%和83.33%，均显著高于对照组（P<0.05）；治疗组治疗后血清CRP水平为（8.33±1.63）mg/L显著低于治疗前和对照组（P<0.05）；治疗组治疗后TC、TG、LDL-C和HDL-C水平分别为（4.37±0.82）mmol/L、（1.96±0.32）mmol/L、（2.45±0.28）mmol/L和（1.38±0.32）mmol/L，均较治疗前和对照组显著改善（P<0.05）。结论舒心胶囊治疗不稳定型心绞痛疗效显著，可抑制炎症反应，改善血脂水平，具有较好的应用和推广价值。
目的：探討舒心膠囊治療不穩定型心絞痛（UAP）的臨床療效及對C-反應蛋白（CRP）和血脂水平的影響。方法將60例UAP患者隨機分為兩組，每組各30例，均給予常規西藥治療，治療組在此基礎上加用舒心膠囊，比較兩組臨床療效及治療前後血清CRP和血脂各項指標變化。結果治療組心絞痛有效率和心電圖有效率分彆為90.00%和83.33%，均顯著高于對照組（P<0.05）；治療組治療後血清CRP水平為（8.33±1.63）mg/L顯著低于治療前和對照組（P<0.05）；治療組治療後TC、TG、LDL-C和HDL-C水平分彆為（4.37±0.82）mmol/L、（1.96±0.32）mmol/L、（2.45±0.28）mmol/L和（1.38±0.32）mmol/L，均較治療前和對照組顯著改善（P<0.05）。結論舒心膠囊治療不穩定型心絞痛療效顯著，可抑製炎癥反應，改善血脂水平，具有較好的應用和推廣價值。
목적：탐토서심효낭치료불은정형심교통（UAP）적림상료효급대C-반응단백（CRP）화혈지수평적영향。방법장60례UAP환자수궤분위량조，매조각30례，균급여상규서약치료，치료조재차기출상가용서심효낭，비교량조림상료효급치료전후혈청CRP화혈지각항지표변화。결과치료조심교통유효솔화심전도유효솔분별위90.00%화83.33%，균현저고우대조조（P<0.05）；치료조치료후혈청CRP수평위（8.33±1.63）mg/L현저저우치료전화대조조（P<0.05）；치료조치료후TC、TG、LDL-C화HDL-C수평분별위（4.37±0.82）mmol/L、（1.96±0.32）mmol/L、（2.45±0.28）mmol/L화（1.38±0.32）mmol/L，균교치료전화대조조현저개선（P<0.05）。결론서심효낭치료불은정형심교통료효현저，가억제염증반응，개선혈지수평，구유교호적응용화추엄개치。
Objective To investigate the ef ect of Shuxin capsule in treatment of unstable angina pectoris and its influence on C- reactive protein and blood lipid level. Methods: 60 cases of UAP were randomly divided into two groups of 30 cases, al patients were treated with conventional western medicine, the treatment group used Shuxin capsule in addition, clinical therapeutic ef ect and changes of serum CRP and blood lipid indices before and after treatment were compared between the two groups. Results The ef ective rate of angina pectoris and ECG were 90% and 83.33% higher than which of the control group (P<0.05); The serum CRP level of the treatment group after treatment was (8.33±1.63) mg/L, significantly lower than that before treatment and the control group (P<0.05);TC, TG, LDL-C and HDL-C levels of the treatment group after treatment were (4.37±0.82),mmol/L (1.96±0.32) mmol/L, (2.45±0.28) mmol/L and (1.38±0.32) mmol/L, significantly improved than before treatment and the control group (P<0.05). Conclusion Shuxin capsule has a significantly ef ect in treatment of unstable angina pectoris which can inhibit inflammatory reaction, improve the blood lipid levels that has a bet er application and popularization value.
